Viral Vector & Plasmid DNA Manufacturing Market
Viral Vector & Plasmid DNA Manufacturing Market Size, Share & Trends Analysis Report
Viral Vector & Plasmid DNA Manufacturing Market Size, Share, Statistics & Trends Analysis By Product Type (Plasmid DNA, Viral Vector, Non Viral Vector) By Application (Cancer, Genetic Disorder, Others) By End User (Hospitals, Ambulatory Surgical Centers, Others) Other Based On Region, And Segment Forecasts, 2025 – 2031
Published
Report ID : BMRC 3544
Number of pages : 300
Published Date : Apr 2025
Category : Healthcare
Delivery Timeline : 48 hrs
Market Segmentation
By Product Type
- Plasmid DNA
- Viral Vector
- Non Viral Vector
By Application
- Cancer
- Genetic Disorder
- Others
By End User
- Hospitals
- Ambulatory Surgical Centers
- Others
Key Players
- Cell and Gene Therapy Catapult
- Lonza
- Diosynth Ltd.
- Spark Therapeutics, Inc.
- FUJIFILM
- Merck KGaA
- Novasep
- CobraBiologics
- Kaneka Eurogentec, Inc.
- UniQure N.V.
SUMMARY
Segments
Market Segmentation
By Product Type
- Plasmid DNA
- Viral Vector
- Non Viral Vector
By Application
- Cancer
- Genetic Disorder
- Others
By End User
- Hospitals
- Ambulatory Surgical Centers
- Others
Regions and Country
North America
- U.S.
- Canada
Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Sweden
- Netherlands
- Turkey
- Switzerland
- Belgium
- Rest of Europe
Asia-Pacific
- South Korea
- Japan
- China
- India
- Australia
- Philippines
- Singapore
- Malaysia
- Thailand
- Indonesia
- Rest of APAC
Latin America
- Mexico
- Colombia
- Brazil
- Argentina
- Peru
- Rest of South America
Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- South Africa
- Rest of MEA
Key Players
Key Players
- Cell and Gene Therapy Catapult
- Lonza
- Diosynth Ltd.
- Spark Therapeutics, Inc.
- FUJIFILM
- Merck KGaA
- Novasep
- CobraBiologics
- Kaneka Eurogentec, Inc.
- UniQure N.V.
